510(k) K771583
K771583 is an FDA 510(k) premarket notification submitted by Burroughs Wellcome Co. for the device "FLUORESCENT ANTI. ANTI-HUMAN C3". The FDA issued a decision of Substantially Equivalent on September 2, 1977. The device falls under product code DAC (Complement C3b Activator, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5260. Burroughs Wellcome Co. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 2, 1977
- Date Received
- August 18, 1977
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Complement C3b Activator, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5260
- Review Panel
- IM
- Submission Type